Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer.
Markowski MC, Ren Y, Tierney M, Royce TJ, Yamashita R, Croucher D, Huang HC, Todorovic T, Chen E, Showalter TN, Carducci MA, Chen YH, Liu G, Parker CTA, Esteva A, Feng FY, Attard G, Sweeney CJ. Markowski MC, et al. Eur Urol Oncol. 2024 Dec 10:S2588-9311(24)00271-2. doi: 10.1016/j.euo.2024.11.009. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39665917
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma.
Singh R, Thotakura AK, Alati S, Lisok A, Jiang Z, Merino VF, Minn I, Yadav S, Markowski MC, Ged Y, Pavlovich CP, Singla N, Solnes LB, Gorin MA, Pomper MG, Rowe SP, Banerjee SR. Singh R, et al. Among authors: markowski mc. Front Oncol. 2024 Sep 10;14:1432286. doi: 10.3389/fonc.2024.1432286. eCollection 2024. Front Oncol. 2024. PMID: 39324008 Free PMC article.
Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction.
Gafita A, Voter A, Shesadri S, Spitz A, Marshall CH, Rowe SP, Markowski MC, Pomper MG, Civelek AC, Carducci MA, Denmeade SR, Young J, Pienta KJ, Paller CJ, Solnes LB. Gafita A, et al. Among authors: markowski mc. J Nucl Med. 2024 Nov 1;65(11):1724-1730. doi: 10.2967/jnumed.124.267723. J Nucl Med. 2024. PMID: 39299783
Gentiana capitata Buch.-Ham. ex D.Don Cell Suspension Culture as a New Source of Isosaponarin and 3,7,8-Trimethoxy-9-oxo-9H-xanthen-1-yl 6-O-β-D-ribopyranosyl-β-D-allopyranoside and Their Effect on PC-12 Cell Viability.
Czarnomska Z, Markowski M, Nawrocka EK, Koźmiński W, Bazylko A, Szypuła WJ. Czarnomska Z, et al. Among authors: markowski m. Int J Mol Sci. 2024 Aug 6;25(16):8576. doi: 10.3390/ijms25168576. Int J Mol Sci. 2024. PMID: 39201264 Free PMC article.
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.
Marshall CH, Teply BA, Lu J, Oliveira L, Wang H, Mao SS, Kelly WK, Paller CJ, Markowski MC, Denmeade SR, King S, Sullivan R, Davicioni E, Proudfoot JA, Eisenberger MA, Carducci MA, Lotan TL, Antonarakis ES. Marshall CH, et al. Among authors: markowski mc. JAMA Oncol. 2024 Oct 1;10(10):1400-1408. doi: 10.1001/jamaoncol.2024.3074. JAMA Oncol. 2024. PMID: 39172479 Clinical Trial.
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial.
Paller CJ, Zahurak ML, Mandl A, Metri NA, Lalji A, Heath E, Kelly WK, Hoimes C, Barata P, Taksey J, Garrison DA, Patra K, Milne GL, Anders NM, Nauroth JM, Durham JN, Marshall CH, Markowski MC, Eisenberger MA, Antonarakis ES, Carducci MA, Denmeade SR, Levine M. Paller CJ, et al. Among authors: markowski mc. Cancer Res Commun. 2024 Aug 1;4(8):2174-2182. doi: 10.1158/2767-9764.CRC-24-0225. Cancer Res Commun. 2024. PMID: 39076107 Free PMC article. Clinical Trial.
165 results